Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

128
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
128
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

258
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
258
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

721
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
721
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

228
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
228
Multi-input and Multi-variable systems01:22

Multi-input and Multi-variable systems

150
Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence...
150
Noncompartmental Analysis: Statistical Moment Theory00:56

Noncompartmental Analysis: Statistical Moment Theory

183
Noncompartmental analyses leverage statistical moment theory to examine time-related changes in macroscopic events, encapsulating the collective outcomes stemming from the constituent elements in play. Statistical moment theory is a mathematical approach used to describe the time course of drug concentration in the body without assuming a specific compartmental model. SMT provides insights into drug absorption, distribution, metabolism, and elimination by treating drug concentration versus time...
183

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

X-Pruning: a dual-stream information fusion mammography diagnosis network based on pruned transformer and cross-attention mechanism.

Quantitative imaging in medicine and surgery·2026
Same author

On the Empirical Power of Goodness-of-Fit Tests in Watermark Detection.

Advances in neural information processing systems·2026
Same author

Dynamic interplay between food addiction, psychological and behavioral factors, and weight-related measures: A longitudinal network analysis in developing youth.

Journal of behavioral addictions·2026
Same author

Correction: Association of intestinal mucosal barrier function with intestinal microbiota in Spleen-Kidney Yang Deficiency IBS-D mice.

Frontiers in microbiology·2026
Same author

Adaptive Integration of Incomplete Multimodal 3D Neuroimaging for Alzheimer's Prediction and Biomarker Discovery.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same author

A powerful representation learning method for enhanced analysis of incomplete multi-omics data.

NPJ systems biology and applications·2026

Related Experiment Video

Updated: Sep 14, 2025

Modeling the Functional Network for Spatial Navigation in the Human Brain
05:55

Modeling the Functional Network for Spatial Navigation in the Human Brain

Published on: October 13, 2023

1.2K

Graph-guided Bayesian Factor Model for Integrative Analysis of Multi-modal Data with Noisy Network Information.

Wenrui Li1, Qiyiwen Zhang1, Kewen Qu1

  • 1Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, 423 Guardian Drive, Philadelphia, 19104, Pennsylvania, U.S.A..

Statistics in Biosciences
|July 22, 2025
PubMed
Summary

This study introduces a novel graph-guided Bayesian factor model to analyze multimodal biological data. The method effectively identifies shared and specific factors while accounting for network noise, improving interpretability in genomics and metabolomics.

Keywords:
Bayesian shrinkageMCMC algorithmfactor analysislatent scale network modelnoisy graph

More Related Videos

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.5K

Related Experiment Videos

Last Updated: Sep 14, 2025

Modeling the Functional Network for Spatial Navigation in the Human Brain
05:55

Modeling the Functional Network for Spatial Navigation in the Human Brain

Published on: October 13, 2023

1.2K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.5K

Area of Science:

  • * Multimodal Data Analysis
  • * Statistical Learning
  • * Bioinformatics

Background:

  • * Existing factor analysis methods struggle to integrate biological network knowledge into multimodal data analysis.
  • * Graph-guided methods improve accuracy but often rely on incomplete or noisy external network data.
  • * Functional genomics and metabolomics data require sophisticated approaches to capture complex biological structures.

Purpose of the Study:

  • * To develop a novel graph-guided Bayesian factor model for multimodal data analysis.
  • * To incorporate and account for noise within biological network information.
  • * To identify globally shared, partially shared, and modality-specific latent factors.

Main Methods:

  • * Proposed a Bayesian factor model incorporating network information from existing databases and estimated graphs.
  • * Utilized a latent scale modeling framework to handle network noise.
  • * Employed shrinkage priors for feature and modal-wise sparsity, enabling feature selection.
  • * Developed an efficient Markov chain Monte Carlo algorithm for posterior sampling.

Main Results:

  • * The proposed model successfully identifies different types of latent factors in multimodal data.
  • * Demonstrated superior performance compared to existing methods through simulations.
  • * Applied the model to gene expression and metabolomics data for Alzheimer's disease research.

Conclusions:

  • * The graph-guided Bayesian factor model offers an interpretable and accurate approach for multimodal data analysis.
  • * The method effectively integrates noisy biological network information for improved factor identification.
  • * This approach has significant potential for applications in complex diseases like Alzheimer's using functional genomics and metabolomics data.